MedDataX Logo

Exercise Therapy for Femoroacetabular Impingement Syndrome

NCT ID: NCT04502043

Last Updated: 2023-12-19

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

RECRUITING

Clinical Phase

NA

Total Enrollment

100 participants

Study Classification

INTERVENTIONAL

Study Start Date

2019-08-01

Study Completion Date

2024-03-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The aim of the clinical trial is to investigate the characteristics of patients, who respond vs. not respond to exercise therapy for the nonsurgical management of femoroacetabular impingement syndrome (FAIS).

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Patients with a diagnosis of FAIS will be recruited from 2 clinical centers and will receive exercise therapy (study intervention). Exercise therapy is a semi-standardized intervention and will last 12 weeks (3 months). Hip pain, function and quality of life will be assessed using a patient-reported questionnaire at baseline, 3, 6 and 12 months' follow-up. Hip joint contact pressure will be evaluated using motion analysis and modelling at baseline, 3 and 12 months' follow-up. Hip morphology will be evaluated using imaging at baseline and hip surgery rate will be evaluated at 6 and 12 months' follow-up.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Femoroacetabular Impingement Syndrome

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

NA

Intervention Model

SINGLE_GROUP

Primary Study Purpose

TREATMENT

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Exercise therapy

Exercise therapy consists of improving dynamic hip joint stability by means of hip-specific and functional lower limb strengthening, core stability and postural balance exercises.

Group Type EXPERIMENTAL

Exercise therapy

Intervention Type OTHER

* Education
* Hip-specific strengthening exercises
* Functional lower limb strengthening exercises
* Core stability exercises
* Postural balance exercises

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Exercise therapy

* Education
* Hip-specific strengthening exercises
* Functional lower limb strengthening exercises
* Core stability exercises
* Postural balance exercises

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Age: 18 to 50 years;
* Diagnosis of FAIS;
* Availability of magnetic resonance arthrography and anteroposterior pelvic radiography of the involved hip;
* Signed informed consent form.

Exclusion Criteria

* Previous hip surgery;
* Any surgery on the lower extremities in the last 6 months;
* Hip dysplasia: lateral center edge angle \<25°;
* Hip osteoarthritis: Tönnis grade \>1;
* BMI: \>35 kg/m2;
* Significant cardiopulmonary diseases.
Minimum Eligible Age

18 Years

Maximum Eligible Age

50 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Kantonsspital Winterthur KSW

OTHER

Sponsor Role collaborator

Schulthess Klinik

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Nicola C Casartelli, PhD

Role: PRINCIPAL_INVESTIGATOR

Schulthess Klinik

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Schulthess Clinic

Zurich, , Switzerland

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

Switzerland

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Nicola C Casartelli, PhD

Role: CONTACT

Phone: 0443857971

Email: [email protected]

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Nicola C Casartelli, PhD

Role: primary

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

SchulthessKlinik

Identifier Type: -

Identifier Source: org_study_id